By the end of 2023, the painkillers market is projected to be valued US$ 70.0 billion, and by the end of 2033, it is projected to have grown at a compound annual growth rate (CAGR) of 3.7% to US$ 100.9 billion. Future Market Insights recently released a study predicting that opioids will hold the largest proportion of the global market in 2022—roughly 53.4%.

The regulatory environment surrounding Painkillers has a big impact on the market’s expansion. These rules are necessary to protect patient safety and stop the overuse and abuse of Painkillers, but too many rules could prohibit people from accessing appropriate pain relief solutions.

Unlock Peak Performance - Get Your Sample Now:
https://www.futuremarketinsights.com/reports/sample/rep-gb-17075

The use of opioid Painkillers have been subject to stronger controls and limitations as a result of heightened scrutiny in recent years. This has given non-narcotic Painkillers like NSAIDs (non-steroidal anti-inflammatory medicines) and other non-narcotic drugs the chance to increase their market share.

The regulatory attempts to enhance pain management and decrease opioid abuse, like prescription drug monitoring programs and physician education initiatives, may present the potential for businesses to provide alternative pain management options.

Clinical advancements in the delivery and formulation of analgesic medications are a constant priority for several top pharmaceutical companies. Additionally, they are creating safer opioids with reduced side effects and efficient pain management.

The creation of analgesic formulations with abuse-deterrent qualities that are more challenging to manipulate for snorting or injection — the methods of administration most frequently associated with addiction due to their rewarding effects — is perhaps the most notable clinical improvement.

Key Players:

  • AbbVie Inc. (Allergan plc)
  • Bristol Myers Squibb Co.
  • Sanofi S.A.
  • Boehringer Ingelheim International GmbH
  • Pfizer Inc.
  • Zydus Lifesciences Ltd. (Cadila Pharmaceuticals)
  • GSK plc.
  • Others

Key Segments:

By Drug Class:

  • Opioids
  • Tramadol
  • Oxycodone
  • Hydrocodone
  • Other Opioids
  • NSAIDs
  • Local Anesthetics
  • Acetaminophen

By Product:

  • OTC Products
  • Prescription Drugs

By Indication:

  • Surgical Pain
  • Cancer Pain
  • Neuropathic Pain
  • Musculoskeletal and Joint Pain
  • Others

By Route of Administration:

  • Injectable
  • Oral
  • Rectal
  • Topical
  • Transdermal
  • Others

By Distribution Channel:

  • Hospital Pharmacies
  • Specialty Clinics
  • Long-Term Care Centers
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Insights Designed for You: Customize Your Exclusive Report Today :
https://www.futuremarketinsights.com/customization-available/rep-gb-17075